MENU
+Compare
MRVI
Stock ticker: NASDAQ
AS OF
Apr 3, 04:59 PM (EDT)
Price
$2.10
Change
-$0.11 (-4.98%)
Capitalization
303.11M

MRVI Maravai LifeSciences Holdings Forecast, Technical & Fundamental Analysis

Maravai LifeSciences Holdings Inc is a life sciences company... Show more

MRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MRVI with price predictions
Apr 02, 2025

MRVI in -8.48% downward trend, sliding for three consecutive days on April 01, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MRVI declined for three days, in of 265 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for MRVI entered a downward trend on April 01, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MRVI's RSI Oscillator exited the oversold zone, of 41 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for MRVI just turned positive on March 17, 2025. Looking at past instances where MRVI's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MRVI advanced for three days, in of 250 cases, the price rose further within the following month. The odds of a continued upward trend are .

MRVI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.976) is normal, around the industry mean (13.260). P/E Ratio (0.000) is within average values for comparable stocks, (64.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.878). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (1.176) is also within normal values, averaging (252.036).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MRVI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MRVI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
MRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MRVI is expected to report earnings to rise 13.83% to -6 cents per share on May 12

Maravai LifeSciences Holdings MRVI Stock Earnings Reports
Q1'25
Est.
$-0.07
Q4'24
Missed
by $0.02
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.05
Q1'24
Missed
by $0.06
The last earnings report on March 18 showed earnings per share of -5 cents, missing the estimate of -3 cents. With 2.52M shares outstanding, the current market capitalization sits at 303.11M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
10770 Wateridge Circle
Phone
+1 858 546-0004
Employees
650
Web
https://www.maravai.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEGYX20.03N/A
N/A
Invesco EQV Intl Small Company Y
FDCAX40.18N/A
N/A
Fidelity Capital Appreciation
JIVCX29.28N/A
N/A
JPMorgan U.S. Applied Data Sci Val C
CLPAX12.00N/A
N/A
Catalyst Nasdaq-100 Hedged Equity A
VARBX10.69N/A
N/A
First Trust Merger Arbitrage Cl I

MRVI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MRVI has been loosely correlated with CRDF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if MRVI jumps, then CRDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRVI
1D Price
Change %
MRVI100%
+2.31%
CRDF - MRVI
38%
Loosely correlated
-1.63%
TECH - MRVI
35%
Loosely correlated
+1.80%
AXON - MRVI
34%
Loosely correlated
+3.18%
VCYT - MRVI
33%
Loosely correlated
+1.93%
OCEA - MRVI
33%
Poorly correlated
-3.64%
More